Literature DB >> 23208667

Iron chelation therapy for a case of transfusion-independent MDS-RARS with significant iron overload.

Haruhiko Ohashi, Kayo Arita, Yasuhiro Suzuki, Akihiro Tomita, Tomoki Naoe, Ai Hattori, Yasuaki Tatsumi, Koichi Kato, Hirokazu Nagai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23208667     DOI： 10.1007/s12185-012-1230-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

1.  Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome.

Authors:  Shohei Kikuchi; Masayoshi Kobune; Satoshi Iyama; Tsutomu Sato; Kazuyuki Murase; Yutaka Kawano; Kohichi Takada; Kaoru Ono; Tsuyoshi Hayashi; Koji Miyanishi; Yasushi Sato; Rishu Takimoto; Junji Kato
Journal:  Int J Hematol       Date:  2012-03-11       Impact factor: 2.490

Review 2.  Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases.

Authors:  Silvia Fargion; Luca Valenti; Anna Ludovica Fracanzani
Journal:  Dig Liver Dis       Date:  2010-08-24       Impact factor: 4.088

3.  Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS.

Authors:  S Park; R Sapena; C Kelaidi; D Vassilieff; D Bordessoule; A Stamatoullas; S Cheze; O Beyne-Rauzy; N Vey; C Rose; A Guerci; Shanti Natarajan-Amé; Gérard Tertian; B Slama; P Fenaux; F Dreyfus
Journal:  Leuk Res       Date:  2011-07-30       Impact factor: 3.156

4.  Frequent pathway mutations of splicing machinery in myelodysplasia.

Authors:  Kenichi Yoshida; Masashi Sanada; Yuichi Shiraishi; Daniel Nowak; Yasunobu Nagata; Ryo Yamamoto; Yusuke Sato; Aiko Sato-Otsubo; Ayana Kon; Masao Nagasaki; George Chalkidis; Yutaka Suzuki; Masashi Shiosaka; Ryoichiro Kawahata; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Ken Ishiyama; Hiraku Mori; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Sumio Sugano; Claudia Haferlach; H Phillip Koeffler; Lee-Yung Shih; Torsten Haferlach; Shigeru Chiba; Hiromitsu Nakauchi; Satoru Miyano; Seishi Ogawa
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

5.  Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes.

Authors:  Norbert Gattermann; Carlo Finelli; Matteo Della Porta; Pierre Fenaux; Michael Stadler; Agnes Guerci-Bresler; Mathias Schmid; Kerry Taylor; Dominique Vassilieff; Dany Habr; Andrea Marcellari; Bernard Roubert; Christian Rose
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

6.  Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

Authors:  Luca Malcovati; Matteo G Della Porta; Daniela Pietra; Emanuela Boveri; Andrea Pellagatti; Anna Gallì; Erica Travaglino; Angela Brisci; Elisa Rumi; Francesco Passamonti; Rosangela Invernizzi; Laura Cremonesi; Jacqueline Boultwood; James S Wainscoat; Eva Hellström-Lindberg; Mario Cazzola
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

7.  Clinicopathological study of Japanese patients with genetic iron overload syndromes.

Authors:  Ai Hattori; Hiroaki Miyajima; Naohisa Tomosugi; Yasuaki Tatsumi; Hisao Hayashi; Shinya Wakusawa
Journal:  Pathol Int       Date:  2012-09       Impact factor: 2.534

8.  Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts.

Authors:  Zachary P Nearman; Hadrian Szpurka; Bianca Serio; Ilka Warshawksy; Karl Theil; Alan Lichtin; Mikkael A Sekeres; Jaroslaw P Maciejewski
Journal:  Am J Hematol       Date:  2007-12       Impact factor: 10.047

9.  Acquired mutations in TET2 are common in myelodysplastic syndromes.

Authors:  Saskia M C Langemeijer; Roland P Kuiper; Marieke Berends; Ruth Knops; Mariam G Aslanyan; Marion Massop; Ellen Stevens-Linders; Patricia van Hoogen; Ad Geurts van Kessel; Reinier A P Raymakers; Eveline J Kamping; Gregor E Verhoef; Estelle Verburgh; Anne Hagemeijer; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

10.  Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.

Authors:  P D Cotter; A May; E J Fitzsimons; T Houston; B E Woodcock; A I al-Sabah; L Wong; D F Bishop
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808
  10 in total
  1 in total

Review 1.  Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome.

Authors:  Niraj Shenoy; Nishanth Vallumsetla; Eliezer Rachmilewitz; Amit Verma; Yelena Ginzburg
Journal:  Blood       Date:  2014-06-12       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.